February 11, 2016 – The European Medicines Agency (EMA) warns that over 100 cases of diabetic ketoacidosis had been reported in patients treated with SGLT2 inhibitors in Europe.
February 11, 2016 – The European Medicines Agency (EMA) warns that over 100 cases of diabetic ketoacidosis had been reported in patients treated with SGLT2 inhibitors in Europe.